Position in NVS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$11,910
New position
Shares Held
76
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,527
of 1,603 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOEY INVESTMENTS, INC holds $4,107,250 across 15 Drug Manufacturers - General names. NVS ranks #9 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
4,928 | $1,784,527 | |
| 2 | ABBV |
AbbVie Inc.
|
4,275 | $1,075,761 | |
| 3 | JNJ |
Johnson & Johnson
|
2,250 | $571,432 | |
| 4 | GSK |
GSK plc
|
4,897 | $256,700 | |
| 5 | LLY |
ELI LILLY & Co
|
187 | $224,293 | |
| 6 | PFE |
Pfizer Inc
|
5,827 | $140,314 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
300 | $17,286 | |
| 8 | AZN |
Astrazeneca PLC
|
77 | $14,600 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,910 | 76 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||